Dan Teufel

 Dan  Teufel
Dan Teufel
Head of Chemistry
Bicycle Therapeutics

Presentations at Drug Discovery 2015

Thu3  Sep10:00am(30 mins)
Development of Cytotoxic Bicyclic Peptide Drug Conjugates and Applications in Molecular Targeted Cancer Therapy

Session: New Biological Drugs & Technologies
Room: To be announced

Profile of Dan Teufel

Dr Teufel has over 15 years of experience in the field of peptide/protein chemistry and biophysics, has authored numerous publications in well-known journals and is an inventor in 8 patents. He has earned his PhD from the University of Cambridge, UK, using extensively modified peptides to decipher the molecular interplay between the tumour suppressor p53 and its regulator p300/CBP. Later, he worked with one of the founders of Bicycle Therapeutics, Sir Gregory Winter, on the early Bicycle Project. After the establishment of Bicycle Therapeutics in 2009, he joined the Company as the leading chemist, building up the peptide chemistry of the Bicycle Therapeutics platform from its foundation. He is currently developing several Bicyclic candidates towards potential application in the clinic, including toxin-linked conjugates.


Poster Presenter
Dr Spencer Campbell
Senior Scientist
Bicycle Therapeutics
Dr Gemma Mudd
Research Scientist
Bicycle Therapeutics
Van Rietschoten
Ms Katerine Van Rietschoten
Research Scientist
Bicycle Therapeutics
Please login to send a Private Message

Hosted By
The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo Find us on Facebook Follow us on Twitter

Get the App
Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
iPhone App
Android App
Eventflo Home
copyright ELRIG, eventflo, Labhoo Ltd 2018